de Andrade DCO - Search Results

1

Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.

Tonacio AC, do Nascimento Pedrosa T, Borba EF, Aikawa NE, Pasoto SG, Filho JCRF, Sampaio Barros MM, Leon EP, Lombardi SCFS, Junior AM, Azevedo AS, Schwarcz WD, Fuller R, Yuki EFN, Ugolini Lopes MR, Rodrigues Pereira RM, Sampaio Barros PD, de Andrade DCO, de Medeiros-Ribeiro AC, de Moraes JCB, Shinjo SK, Miossi R, da Silva Duarte AJ, Lopes MH, Kallás EG, Almeida da Silva CA, Bonfá E. Tonacio AC, et al. Among authors: de andrade dco. PLoS Negl Trop Dis. 2021 Nov 29;15(11):e0010002. doi: 10.1371/journal.pntd.0010002. eCollection 2021 Nov. PLoS Negl Trop Dis. 2021. PMID: 34843469 Free PMC article. Clinical Trial.

2

ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?

Nascimento NM, Bydlowski SP, Soares RP, de Andrade DC, Bonfá E, Seguro LP, Borba EF. Nascimento NM, et al. J Thromb Thrombolysis. 2015 Oct;40(3):374-8. doi: 10.1007/s11239-015-1176-8. J Thromb Thrombolysis. 2015. PMID: 25638331 Clinical Trial.

3

Enhanced type I interferon gene signature in primary antiphospholipid syndrome: Association with earlier disease onset and preeclampsia.

Ugolini-Lopes MR, Torrezan GT, Gândara APR, Olivieri EHR, Nascimento IS, Okazaki E, Bonfá E, Carraro DM, de Andrade DCO. Ugolini-Lopes MR, et al. Among authors: de andrade dco. Autoimmun Rev. 2019 Apr;18(4):393-398. doi: 10.1016/j.autrev.2018.11.004. Epub 2019 Feb 14. Autoimmun Rev. 2019. PMID: 30772492

4

Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS).

Rosa RF, Ugolini-Lopes MR, Gandara APR, Vendramini MBG, Campanholo KR, Dutra L, de Andrade DCO. Rosa RF, et al. Among authors: de andrade dco. Rheumatology (Oxford). 2021 Jan 5;60(1):179-187. doi: 10.1093/rheumatology/keaa252. Rheumatology (Oxford). 2021. PMID: 32613245

5

Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.

Nascimento IS, Radin M, Gândara APR, Sciascia S, de Andrade DCO. Nascimento IS, et al. Among authors: de andrade dco. Lupus. 2020 Jun;29(7):676-685. doi: 10.1177/0961203320916527. Epub 2020 Apr 11. Lupus. 2020. PMID: 32279584

6

Identification of Autoimmunity to Peptides of Collagen V α1 Chain as Newly Biomarkers of Early Stage of Systemic Sclerosis.

Velosa APP, Brito L, de Jesus Queiroz ZA, Carrasco S, Tomaz de Miranda J, Farhat C, Goldenstein-Schainberg C, Parra ER, de Andrade DCO, Silva PL, Capelozzi VL, Teodoro WR. Velosa APP, et al. Among authors: de andrade dco. Front Immunol. 2021 Feb 12;11:604602. doi: 10.3389/fimmu.2020.604602. eCollection 2020. Front Immunol. 2021. PMID: 33643291 Free PMC article.

7

High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis.

de Andrade DC, de Magalhães Souza SC, de Carvalho JF, Takayama L, Borges CT, Aldrighi JM, Pereira RM. de Andrade DC, et al. Rheumatol Int. 2012 Jun;32(6):1549-53. doi: 10.1007/s00296-011-1821-2. Epub 2011 Feb 16. Rheumatol Int. 2012. PMID: 21327426

8

Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS).

Balbi GGM, Pacheco MS, Monticielo OA, Funke A, Danowski A, Santiago MB, Staub HL, Rêgo J, de Andrade DCO. Balbi GGM, et al. Among authors: de andrade dco. Adv Rheumatol. 2020 May 27;60(1):29. doi: 10.1186/s42358-020-00125-9. Adv Rheumatol. 2020. PMID: 32460902 Review.

9

Oxygen uptake kinetics and chronotropic responses to exercise are impaired in survivors of severe COVID-19.

Longobardi I, Prado DMLD, Goessler KF, Meletti MM, de Oliveira Júnior GN, de Andrade DCO, Gualano B, Roschel H. Longobardi I, et al. Among authors: de andrade dco. Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H569-H576. doi: 10.1152/ajpheart.00291.2022. Epub 2022 Aug 19. Am J Physiol Heart Circ Physiol. 2022. PMID: 35984763 Free PMC article.

10

Effects of a 16-week home-based exercise training programme on health-related quality of life, functional capacity, and persistent symptoms in survivors of severe/critical COVID-19: a randomised controlled trial.

Longobardi I, Goessler K, de Oliveira Júnior GN, Prado DMLD, Santos JVP, Meletti MM, de Andrade DCO, Gil S, Boza JASO, Lima FR, Gualano B, Roschel H. Longobardi I, et al. Among authors: de andrade dco. Br J Sports Med. 2023 Oct;57(20):1295-1303. doi: 10.1136/bjsports-2022-106681. Epub 2023 May 10. Br J Sports Med. 2023. PMID: 37164620 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page